Peterson decision rests with Nevada Commission
The blockbuster rematch between Amir Khan and WBA and IBF light-welterweight ruler Lamont Peterson rests in the hands of the Nevada State Athletic Commission (NSAC) after the Washington fighter failed a drugs test.
Peterson tested positive for synthetic testosterone ahead of the May 19 bout at the Manadalay Bay in Las Vegas but, in a statement from his team, revealed that he used the banned substance before the pair’s first meeting last year.
Peterson’s camp told the Nevada Commission in a letter that the fighter was administered the drug last year November after being diagnosed with an abnormal or low testosterone level.
The letter obtained by RingTV.com also states that ‘the medical reports substantiate that the treatment was not in any manner intended for enhancement of athletic performance, and, moreover, the prescribed single treatment would not produce a significant enhancement of athletic performance.’
On Tuesday Golden Boy CEO Richard Schaefer issued a statement confirming that Khan would continue to train for the fight until it was otherwise called off by the NSAC.
Schaefer admitted he was miffed that the news of the positive test was furnished to Keith Kizer, head of the Nevada Commission, and counsel for the Voluntary Anti-Doping Association (VADA) and Peterson, and not him.
Revealing Peterson had tested positive in his A sample on April 12 and then again in his B sample on April 30 before Golden Boy or Team Khan had been notified, Schaefer questioned the delay in the second test and news reaching his team.
The NSAC will now review all the medical reports and explanations by Peterson’s camp before making a decision on whether or not to grant the fighter a licence for the May 19 bout.